Combination of gemcitabine and adoptive cell therapy of autologous anti-tumor CTL induces clinical activities in patients with refractory lung cancer No significant financial relationships to disclose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback